Diagnostic News and Research

RSS

Gentic circuits that cause mucous hyper-production identified

Scientists have identified the main genetic switch that causes excessive mucous in the lungs, a discovery that one day could ease suffering for people with chronic lung diseases like asthma and cystic fibrosis, or just those fighting the common cold.

15 Sep 2009

Outreach and Registry Program to help combat and treat Alzheimer's disease

Today Senator Jay Rockefeller announced an unprecedented and powerful partnership to help combat and treat Alzheimer's disease in West Virginia.

15 Sep 2009

Genetic switch that causes excessive mucus in the lungs identified

Scientists have identified the main genetic switch that causes excessive mucus in the lungs, a discovery that one day could ease suffering for people with chronic lung diseases like asthma and cystic fibrosis, or just those fighting the common cold.

15 Sep 2009

Innovative treatments for bowel dysfunction

Twenty percent of all Albertans are plagued by symptoms of diarrhea, constipation, abdominal pain, bloating, and gas. More than an inconvenience for many, these problems are rarely discussed in public, leaving sufferers feeling isolated. Yet bowel symptoms can be disabling, greatly impairing quality of life.

15 Sep 2009

Mild cognitive impairment is a risk factor for dementia

Among individuals with mild cognitive impairment, often considered a transitional state between normal cognitive function and Alzheimer's dementia, those who have more difficulties performing routine activities appear more likely to progress quickly to dementia, according to a report in the September issue of Archives of Neurology, one of the JAMA/Archives journals.

15 Sep 2009

Third-quarter fiscal 2009 results announced by DiagnoCure

DiagnoCure Inc. (TSX: CUR), a life sciences company commercializing high-value cancer diagnostic tests and delivering laboratory services, announced revenue of $396,468 and a net loss of $4,034,364 or $0.09 per share for the third quarter ending July 31, 2009.

15 Sep 2009

FDA clears Diagnostic HYBRIDS' D3 FastPoint L-DFA Respiratory Virus Identification Kit

Diagnostic HYBRIDS, a leading developer of IVD fluorescent staining kits and cell culture products, today announced the U.S. Food and Drug Administration (FDA) (510k) clearance of its D3 FastPointTM L-DFATM Respiratory Virus Identification Kit, which allows the individual detection of influenza A, influenza B, respiratory syncytial virus (RSV), human metapneumovirus (hMPV), adenovirus and parainfluenza viruses from a patient’s specimen in under 30 minutes.

15 Sep 2009

Emerging Growth Research to manage investor relations programs for Biomagnetics Diagnostics

Biomagnetics Diagnostics Corp., a producer of revolutionary diagnostic systems and technology for HIV, hepatitis, tuberculosis, and malaria detection, today announced it has retained Emerging Growth Research, LLP to manage its public relations and investor relations programs. Emerging Growth Research specializes in small market capitalization companies in the technology and biotechnology sectors.

14 Sep 2009

Boston Scientific to market Bladder Health Network's female urodynamic testing solutions in the U.S.

Boston Scientific Corporation (NYSE: BSX) today announced that it has entered into a co-marketing agreement with Bladder Health Network, a privately held company offering advanced testing solutions for urinary incontinence. Bladder Health Network offers an integrated diagnostic service that combines staffing, equipment, supplies and results analysis, helping to ensure that physicians and their patients have access to testing, interpretation and treatment options for urinary incontinence and other problems related to the urinary system.

14 Sep 2009

ODS Health Plan selects American Imaging Management to provide diagnostic imaging services

American Imaging Management(R) (AIM), an operating subsidiary of WellPoint, Inc. (NYSE: WLP), and one of the leading imaging benefit management and technology companies with health plan clients representing over 35 million consumers, announced that it has been selected by ODS Health Plan, Inc. to provide diagnostic imaging services. Under the agreement, AIM will administer diagnostic imaging management services to ODS members in Oregon and surrounding service areas.

14 Sep 2009

Spacelabs Healthcare launches its Sentinel Cardiology Information Management System in the U.S.

OSI Systems, Inc. (NASDAQ: OSIS), a vertically-integrated provider of specialized electronic products for critical applications in the Security and Healthcare industries, today announced that its Healthcare division, Spacelabs Healthcare, has launched the Sentinel Cardiology Information Management System (“CIMS”) in the United States.

14 Sep 2009

HFSA annual meeting features discussion on David Duncan's quest for personalized medicine

The 13th Annual Scientific Meeting of the Heart Failure Society of America (HFSA) today featured a discussion by David Ewing Duncan titled "One Man's Quest for Personalized Medicine." Over the course of one year, Duncan submitted himself to hundreds of tests that could predict and even prevent future illness.

14 Sep 2009

FDA approves St. Jude Medical's EnSite Velocity Cardiac Mapping System

St. Jude Medical, Inc. (NYSE: STJ) today announced U.S. Food and Drug Administration (FDA) clearance and U.S. launch of its EnSite Velocity™ Cardiac Mapping System. This new system has been designed to help physicians more efficiently diagnose and guide therapy to treat abnormal heart rhythms.

14 Sep 2009

Tenet announces revisions to its outlook for 2009

Tenet Healthcare Corporation (NYSE: THC) today announced revisions to its outlook for 2009 Adjusted EBITDA to a new range of $900 million to $950 million. The prior outlook range was $810 million to $875 million. This new range corresponds to an outlook for net income attributable to shareholders in a range of $76 million to $141 million. Adjusted EBITDA is a non-GAAP term defined and reconciled to GAAP net income below.

14 Sep 2009

Digital Pathology Association has another Gold Sponsor: Sunquest Information Systems

Sunquest Information Systems, Inc., a market leader in laboratory and diagnostic information systems, today announced that it is a Founding Gold Sponsor of the Digital Pathology Association (DPA), a non-profit organization committed to the advancement of digital pathology applications in healthcare. The goals of the DPA include supporting digital pathology education initiatives, defining best practices, influencing standards and interfaces, organizing an annual conference that addresses diverse needs within the industry, and more.

From Evident Corporation - Life Sciences 14 Sep 2009

Genoptix to present an overview of its specialized diagnostic laboratory services business

Genoptix, Inc., a specialized laboratory services provider, today announced the Company's participation at the following upcoming investor conferences.

14 Sep 2009

Patni Computer to provide design and development services to Cardiac Science Corporation

Cardiac Science Corporation (Nasdaq: CSCX), a global leader in automated external defibrillator (AED) and diagnostic cardiac monitoring devices, announced a three-year agreement with Patni Computer Systems under which Patni will establish a dedicated design center in India and will expand Cardiac Science's existing in-house design and development capability.

14 Sep 2009

Schizophrenia: A major public health problem

Schizophrenia is a major public health problem. Affecting almost 1% of the world's population, it takes an enormous economic and social toll in addition to the distress, dysfunction, disability and mortality for those afflicted with this disease. Elements of the disease are present from birth, other aspects emerge during developmental years, and the illness becomes fully expressed in early adulthood with long-lasting implications for most patients.

14 Sep 2009

Natus Medical to purchase Alpine Biomed Holdings

Natus Medical Incorporated today announced that it has entered into an agreement to acquire Alpine Biomed Holdings Corp in a transaction that is expected to close today.

14 Sep 2009

Quest Diagnostics' OVA1 ovarian cancer test cleared by the FDA

The U.S. Food and Drug Administration (FDA) today cleared the OVA1(TM) Test, the first blood test that, prior to surgery, can help physicians determine if a woman is at risk for a malignant pelvic mass. OVA1 is the first FDA-cleared laboratory test that can indicate the likelihood of ovarian cancer with high sensitivity prior to biopsy or exploratory surgery, even if radiological test results fail to indicate malignancy.

From Quest Diagnostics 14 Sep 2009

Diagnostic News and Research

Gentic circuits that cause mucous hyper-production identified

Outreach and Registry Program to help combat and treat Alzheimer's disease

Genetic switch that causes excessive mucus in the lungs identified

Innovative treatments for bowel dysfunction

Mild cognitive impairment is a risk factor for dementia

Third-quarter fiscal 2009 results announced by DiagnoCure

FDA clears Diagnostic HYBRIDS' D3 FastPoint L-DFA Respiratory Virus Identification Kit

Emerging Growth Research to manage investor relations programs for Biomagnetics Diagnostics

Boston Scientific to market Bladder Health Network's female urodynamic testing solutions in the U.S.

ODS Health Plan selects American Imaging Management to provide diagnostic imaging services

Spacelabs Healthcare launches its Sentinel Cardiology Information Management System in the U.S.

HFSA annual meeting features discussion on David Duncan's quest for personalized medicine

FDA approves St. Jude Medical's EnSite Velocity Cardiac Mapping System

Tenet announces revisions to its outlook for 2009

Digital Pathology Association has another Gold Sponsor: Sunquest Information Systems

Genoptix to present an overview of its specialized diagnostic laboratory services business

Patni Computer to provide design and development services to Cardiac Science Corporation

Schizophrenia: A major public health problem

Natus Medical to purchase Alpine Biomed Holdings

Quest Diagnostics' OVA1 ovarian cancer test cleared by the FDA

Discover how SciY empowers scientists

Why use light scattering to analyze proteins and viral vectors?

Changing the landscape of R&D to build clinical success from the ground up

Latest News